Analysts Applaud UiPath’s AI Traction, But Net New ARR Slide Sparks Caution

UiPath reports strong Q1 results, raises FY26 guidance, and sees early success with agentic AI initiatives. Analysts increase price targets. Latest Ratings for PATH Date Firm Action From To Jan 2022 Macquarie Upgrades Neutral Outperform Jan 2022 Macquarie Upgrades Neutral Outperform Jan 2022 Oppenheimer Upgrades Perform Outperform View More Analyst Ratings for PATH View the…

Read More